Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 132.75 | (20.14) | (29.56)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 45.25 | (145.37) | (176.80)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Glaxo to top up Theravance stake | 02-Apr-2012 | ShareCast |
| Question marks remain over Glaxo drug Relovair | 09-Jan-2012 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 22.02 |
| Change Today | $ 0.19 |
| % Change | 0.87 % |
| 52 Week High | $26.13 |
| 52 Week Low | $16.39 |
| Volume | 258,606 |
| Shares Issued | 86.54m |
| Market Cap | $1,905.66m |
| Beta | 1.68 |
| RiskGrade | 261 |
| Strong Buy | 6 |
| Buy | 1 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 11 |

| Time | Volume / Share Price |
| 16:00 | 18,270 @ $22.02 |
| 15:59 | 200 @ $22.05 |
| 15:59 | 400 @ $22.04 |
| 15:59 | 258 @ $22.05 |
| 15:59 | 100 @ $22.05 |
You are here: research